市場調査レポート
商品コード
1123247
ジェットインジェクターの世界市場:予測(2022年~2028年)Global Jet Injector Market Research and Forecast 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ジェットインジェクターの世界市場:予測(2022年~2028年) |
出版日: 2022年08月01日
発行: Orion Market Research
ページ情報: 英文 125 Pages
納期: 2~3営業日
|
世界のジェットインジェクターの市場規模は、予測期間(2022年~2028年)中に非常に高いCAGRで成長すると予想されています。ドラッグデリバリー技術における最新技術の必要性、技術の進歩、バイオシミラー製品の需要に伴う医療支出の増加は、ジェットインジェクター市場の成長を促進しています。
当レポートでは、世界のジェットインジェクター市場について調査分析し、市場概要、競合情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。
カテゴリー:医薬品 1. レポート概要
Global Jet Injector Market Size, Share & Trends Analysis Report by Product (Prefilled Needle-Free Injectors and Fillable Needle-Free Injectors), By Application (Insulin Delivery, Respiratory Delivery, Vaccine Delivery, and Others), By Technology (Jet Based, Spring Based, Laser Power Based and Vibration Based), By End-User (Pharmaceutical Companies, Hospital & Clinical Centers and Others) Forecast Period 2021-2027
The global Jet Injector market is growing at a considerable CAGR during the forecast period. The jet injector or needle-free device is a medical device that is used for vaccination and drug delivery by the high-pressure narrow jet of fluid. The major factors that are augmenting the growth of the market include the need for modern technologies in drug delivery technology, the growing prevalence of chronic diseases such as diabetes and cancer among others.
Furthermore, increasing demand for self-injection devices, reduction in risks such as cross-contamination, pain-free devices for patients, and various FDA and government approvals for the needle-free jet injectors are also estimated to be the major factors that are contributing significantly towards the growth of the market. In addition to this, the vaccination for the ongoing COVID-19 pandemic is expected to fuel the market. For Instance, Codagenix's intranasal COVID-19 vaccine does not require the needle to be administered.
However, certain factors are affecting the growth of the market. High development cost, and the need to ensure system sterility are the major constraints that will challenge the growth of the jet injector market across the globe. Conversely, technological advancement and rise in healthcare expenditures with the demand for biosimilar products are opportunities for the market to grow in the forecast period.
Segmental Outlook
The market is segmented on the basis of product, application, technology, and end-user. By product, the market is segmented into prefilled needle-free injectors and fillable needle-free injectors. Based on the application segment, the market is segmented into insulin delivery, respiratory diseases, vaccine delivery, and others. Insulin delivery is expected to hold a major market share during the forecast period. The market growth is mainly driven by the rise in diabetes across the globe. According to the International Diabetes Federation (IDF), 463 million people globally have diabetes and the low-and middle-income countries are affected more. Moreover, it is one of the leading causes of mortalities across the globe as around 1.6 million mortalities are due to diabetes each year. Therefore, the market is estimated to grow even more in the forecast period due to the rise of the geriatric population.
Further, based on the technology segment, the market is segmented into jet-based, spring-based, laser power-based, and vibration-based. In addition to this, based on the end-user segment, the market is segmented into pharmaceutical companies, hospitals, and clinical centers, and others.
Global Jet Injector Share by Application, 2020 (%)
Global Jet Injector Share by Application
Regional Outlooks
The global jet injector market is analyzed on the basis of the geographical regions that are contributing significantly to the growth of the market. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to be one of the leading regions in the global jet injector market. Rising demand for self-administration healthcare facilities, mergers, and acquisitions by major players, rise in chronic diseases such as diabetes and cancer, and technological advancement are the major factors that fuel the market growth in North America. The US accounts for a major share in this region. Asia Pacific is estimated to be one of the fastest-growing regions during the forecast period. The rise in diabetes patients in the countries including India and China and the increase in government funding in this region are the factors that will grow the market in the forecast period. For instance, according to the International Diabetes Federation (IDF), 88 million people had diabetes in the Southeast Asia region out of which 77 million people were of India.
Global Jet Injector Market Growth, by Region 2021-2027
Global Jet Injector Market Growth, by Region
Market Players Outlook
The jet injector market is fragmented however some players are actively contributing to the market. Key players of the jet injector market include European Pharma Group BV, Crossject SA, INJEX Pharma GmbH, and Pharmajet. In order to survive in the market, these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on.
The Report Covers
Market value data analysis of 2019 and forecast to 2026.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global female infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.